On February 12th, an FDA advisory panel recommended overwhelmingly that the agency approve a drug called esketamine for the rapid relief of depression in patients who have not been helped by existing…
Read More
Although many studies in recent years have provided evidence that ketamine, an anesthetic drug, can provide rapid relief to people with deep depression, this research has not shed much light on what…
Read More
Alan F. Schatzberg, M.D.
Stanford University School of Medicine
Scientific Council Member (Joined 2005)
2005 Falcone Prizewinner for Outstanding Achievement in
Affective Disorders Research (Colvin…
Read More
A small study of intravenous ketamine treatment for adolescents with treatment-resistant depression indicates that the drug may be an effective treatment for at least some teens, according to a new…
Read More
The experimental drug esketamine rapidly reduced thoughts of suicide and symptoms of depression in a small clinical trial reported April 16 in the American Journal of Psychiatry.
Read More
